Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Mar;49(1):54-58.

Suspected Heparin-Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation

Bhupinder Natt  1 , Cameron Hypes  2 , Robyn Basken  3 , Joshua Malo  1 , Toshinobu Kazui  4 , Jarrod Mosier  2
Affiliations
Case Reports

Suspected Heparin-Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation

Bhupinder Natt et al. J Extra Corpor Technol. 2017 Mar.

Abstract

Heparin-induced thrombocytopenia (HIT) is an immune reaction usually secondary to unfractionated heparin. Anticoagulation management is critical in patients while on extracorporeal membrane oxygenation (ECMO) to prevent thromboembolism and for the optimal functioning of the circuit. We identified five patients with respiratory failure at our hospital managed with ECMO in the last 2 years that were treated for HIT. A brief clinical course and their management are discussed. We also briefly review the literature for best evidence for management of such patients.

Keywords: ECMO; HIT; antibody; anticoagulation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Extracorporeal Life Support Organization (ELSO) Guidelines for Cardiopulmonary Extracorporeal Life Support. Version 1.3. Published November 2013. Ann Arbor, MI: Available at: www.elsonet.org. Accessed December 11, 2016
    1. Lequier L., Annich G., Massicotte P.. Anticoagulation and Bleeding in ECLS. Extracorporeal Cardiopulmonary Support in Critical Care (4th ed.). Ann Arbor, MI: ELSO; 2012.
    1. Maul T. M., Massicotte M. P., Wearden P. D.. ECMO biocompatibility: Surface coatings, anticoagulation, and coagulation monitoring, extracorporeal membrane oxygenation—Advances in therapy, Dr. Michael Firstenberg (Ed.), InTech, 2016. Available at: http://www.intechopen.com/books/extracorporeal-membrane-oxygenation-adva...
    1. Salter B. S., Weiner M. M., Trinh M. A., et al. . Heparin-induced thrombocytopenia. A comprehensive clinical review. J Am Coll Cardiol. 2016;67:2519–32. - PubMed
    1. Greinacher A., Warkentin T. E.. Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis. Expert Rev Hematol. 2008;1:75–85. - PubMed

Publication types

LinkOut - more resources